Medivation Enters into Confidentiality Agreements, Including with Sanofi

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Medivation Enters into Confidentiality Agreements, Including with Sanofi

3 Key Takeaways as Medivation (MDVN) Enters Next Phase of Takeover Talks

July 6, 2016 7:56 AM EDT

After the close Tuesday, Medivation (Nasdaq: MDVN) announced it entered confidentiality agreements with Sanofi (NYSE: SNY) and a number of other parties that have expressed interest acquiring the company. Before entering into the confidentiality agreement with Sanofi, Medivation rejected the latest offer from Sanofi - $58.00 per share in cash plus a Contingent Value Right for talazoparib of up to $3.00 per share. In addition to... More